MedTrace Logo

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

NCT06484881 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-10-15

No results posted yet for this study

Summary

The primary objective of the study is to assess the efficacy of DA-001 as an oral supplement for treatment of female pattern hair loss.

Conditions

Interventions

DIETARY_SUPPLEMENT

Daniel Alain Probiotic Treatment for Androgenetic Alopecia

Probiotic

DRUG

Topical minoxidil 5%

Topical minoxidil 5%

Sponsors & Collaborators

  • Follea International Limited

    collaborator INDUSTRY

  • Applied Biology, Inc.

    lead INDUSTRY

Principal Investigators

  • Andy Goren, MD · University of Rome G. Marconi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-15
Primary Completion
2024-10-10
Completion
2024-10-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484881 on ClinicalTrials.gov